It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to ...

[23] Thus, the options should be fully discussed ... goal is to provide cardiac protection and osteoporosis prophylaxis, then long-term treatment is needed, possibly over a lifetime.

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to ...

Thacker HL. Update on Hormone Replacement: Sorting Out the Options for Preventing Coronary Artery Disease and Osteoporosis. MedGenMed 1(1), 1999 [formerly published in Medscape Women's Health ...

A breakthrough in Taiwan could mean earlier diagnosis and personalized treatment for those suffering from arthritis and ...

Because there are typically no symptoms until the first fracture occurs, osteoporosis is considered a silent disease. Some call it a silent killer. Osteoporosis is a bone disease characterized by ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by ...

suggesting they could be useful markers for diagnosing or treating both rheumatoid arthritis and osteoporosis,” said Lo. With ...

Protein Blocking Bone Development Could Hold Clues for Future Osteoporosis Treatment Oct. 11, 2024 — Scientists have identified a protein that blocks the activity of bone-forming cells ...

Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced the dosing ...

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...